Diseases & Disorders
(G30)
IRS Verified
DX Registered
990 on File
BARBARA ANN KARMANOS CANCER HOSPITAL
Financial strength (30%)
73/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$606.8M
Total Revenue
$551.1M
Total Expenses
$84.4M
Net Assets
1156
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
90.8%
Fundraising Efficiency
N/A
Operating Reserve
1.84x
Liability-to-Asset
64.8%
Revenue Diversification
99.3%
Executive Compensation
$2.0M
Compared with Peers
FY 2025
Compared with 21 similar organizations
(United States, Diseases & Disorders, $100M and over in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
90.8% | 83.9% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.3% | 8.8% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.8% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
1.8 mo | 8.2 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
64.8% | 31.3% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.3% | 94.4% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
6.0% | 8.2% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
8.2% | 7.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
9.2% | 0.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $606.8M | $551.1M | $84.4M | 90.8% | 1156 |
| 2024 | $572.6M | $509.4M | $76.2M | 89.8% | 1125 |
| 2023 | $468.9M | $434.7M | $156.1M | 90.9% | 1158 |
| 2022 | $402.5M | $377.6M | $45.0M | 88.0% | 1171 |
| 2021 | $374.9M | $354.3M | N/A | — | 1130 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.